Trial Profile
A Pilot Study of Aromatase Inhibitors for Women at Increased Risk of Breast Cancer Based on Estradiol Levels
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Ethinylestradiol/norethisterone
- Indications Breast cancer; Cardiovascular disorders; Ductal carcinoma; Menopausal syndrome; Myocardial ischaemia
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Acronyms WISE
- 14 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.